The TPM of the NPM1 gene was equal to 1492 in AML-T0 (median), 752 in AML-T1 and 799 in HV (mean), indicating a twofold increase in leukemia at the time of diagnosis and a decrease after therapy to the level typical for HV. This evidence concerns the gene NPM1 and leukemia.